PerkinElmer Buys Haoyuan Biotech, a Diagnostics Company, for $38 Million
PerkinElmer paid $38 million to buy Shanghai Haoyuan Biotech Co., a company that has developed four SFDA-approved infectious disease diagnostic tests. The owners of Haoyuan may also receive future payments based on revenues hitting targets. The four assays, which test for hepatitis B, hepatitis C and HIV, are intended for use by blood banks and clinical labs. More details.... Stock Symbol: (NYSE: PKI) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});  
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here